Aspira Women's Health Inc. (AWH)
$0.08
$0.00
(-4.39%)
As on 16-May-2025 09:30EDT
Market cap
$3 Mln
Revenue (TTM)
$7 Mln
P/E Ratio
--
P/B Ratio
5
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-7.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.1
-
Debt to Equity
-0.5
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
35,224,300
10 Years Aggregate
CFO
$-169.81 Mln
EBITDA
$-194.42 Mln
Net Profit
$-177.61 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aspira Women's Health (AWH)
| -88.9 | -16.3 | -66.8 | -97.2 | -77.4 | -71.2 | -44.4 |
|
BSE Sensex*
| -12.3 | -4.4 | -3.7 | -10.2 | 3.1 | 4.7 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|
|
Aspira Women's Health (AWH)
| -18.2 | -73.6 | 728.4 | 170.0 | -84.3 | 103.2 |
|
S&P Small-Cap 600
| 13.9 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aspira Women's Health (AWH)
|
0.1 | 2.9 | 7.0 | -8.5 | -181.4 | -- | -- | 5.0 |
| 2.6 | 274.4 | 17.5 | -43.2 | -172.4 | -107.8 | -- | 6.2 | |
| 1.1 | 135.3 | 78.8 | -96.9 | -53.3 | -- | -- | 3.4 | |
| 56.7 | 5,000.9 | 13.4 | -451.1 | -3,529.8 | -24.6 | -- | 2.9 |
Shareholding Pattern
View DetailsAbout Aspira Women's Health (AWH)
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum... test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz for the generation of a multi-omic, non-invasive diagnostic aid to identify endometriosis based on circulating miRNAs and proteins; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas. Read more
-
CEO & Director
Ms. Nicole Sandford C.P.A.
-
CEO & Director
Ms. Nicole Sandford C.P.A.
-
Headquarters
Austin, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aspira Women's Health (AWH)
What is the current share price of Aspira Women's Health Inc (AWH) Today?
The share price of Aspira Women's Health Inc (AWH) is $0.08 (NASDAQ) as of 16-May-2025 09:30 EDT. Aspira Women's Health Inc (AWH) has given a return of -77.37% in the last 3 years.
What is the current PB & PE ratio of Aspira Women's Health Inc (AWH)?
Since, TTM earnings of Aspira Women's Health Inc (AWH) is negative, P/E ratio is not available.
The P/B ratio of Aspira Women's Health Inc (AWH) is 5.02 times as on 16-May-2025, a 95 premium to its peers’ median range of 2.58 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
What is the 52 Week High and Low of Aspira Women's Health Inc (AWH)?
The 52-week high and low of Aspira Women's Health Inc (AWH) are Rs -- and Rs -- as of 20-Sep-2026.
What is the market cap of Aspira Women's Health Inc (AWH)?
Aspira Women's Health Inc (AWH) has a market capitalisation of $ 3 Mln as on 16-May-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Aspira Women's Health Inc (AWH)?
Before investing in Aspira Women's Health Inc (AWH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.